Luc Farmer,Randy Scott Bethiel,Dylan Jacobs,Robert B. Perni,John Maxwell,Kevin Cottrell,Summer Halas
申请号：
US12528952
公开号：
US08575208B2
申请日:
2008.02.20
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.
